These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24898608)

  • 1. Multimodal nanoprobes evaluating physiological pore size of brain vasculatures in ischemic stroke models.
    Zheng S; Bai YY; Changyi Y; Gao X; Zhang W; Wang Y; Zhou L; Ju S; Li C
    Adv Healthc Mater; 2014 Nov; 3(11):1909-18. PubMed ID: 24898608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
    Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
    J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
    Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
    J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT; Zhao JG; Li MH; Li YD
    Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient oxygen-glucose deprivation sensitizes brain capillary endothelial cells to rtPA at 4h of reoxygenation.
    Kuntz M; Mysiorek C; Pétrault O; Boucau MC; Aijjou R; Uzbekov R; Bérézowski V
    Microvasc Res; 2014 Jan; 91():44-57. PubMed ID: 24333620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
    Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
    Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes.
    Fan X; Jiang Y; Yu Z; Yuan J; Sun X; Xiang S; Lo EH; Wang X
    Adv Pharmacol; 2014; 71():391-410. PubMed ID: 25307224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement.
    Zheng S; Bai YY; Liu Y; Gao X; Li Y; Changyi Y; Wang Y; Chang D; Ju S; Li C
    Biomaterials; 2015 Oct; 66():9-20. PubMed ID: 26188608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats.
    Turner RJ; Vink R
    Neuroscience; 2012 Sep; 220():1-10. PubMed ID: 22750240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
    Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
    Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
    Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
    Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of Biomembrane-mimetic Nanoparticles for the Treatment of Ischemic Stroke].
    Fukuta T
    Yakugaku Zasshi; 2021; 141(9):1071-1078. PubMed ID: 34471008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
    Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo optical imaging of ischemic blood-brain barrier disruption.
    Abulrob A; Brunette E; Slinn J; Baumann E; Stanimirovic D
    Methods Mol Biol; 2011; 763():423-39. PubMed ID: 21874469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.
    Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C
    Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.
    Maeda M; Furuichi Y; Noto T; Matsuoka N; Mutoh S; Yoneda Y
    Brain Res; 2009 Feb; 1254():99-108. PubMed ID: 19101526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of angiopoietin-like 4 on the blood-brain barrier in acute ischemic stroke treated with thrombolysis in mice.
    Zhang B; Xu X; Chu X; Yu X; Zhao Y
    Neurosci Lett; 2017 Apr; 645():113-120. PubMed ID: 28267563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.